Hepatocyte nuclear factor 4α and cancer-related cell signaling pathways: a promising insight into cancer treatment

DD Lv, LY Zhou, H Tang - Experimental & molecular medicine, 2021 - nature.com
Hepatocyte nuclear factor 4α (HNF4α), a member of the nuclear receptor superfamily, is
described as a protein that binds to the promoters of specific genes. It controls the …

[HTML][HTML] Role of hepatocyte nuclear factor 4-alpha in gastrointestinal and liver diseases

MM Yeh, DE Bosch, SS Daoud - World journal of gastroenterology, 2019 - ncbi.nlm.nih.gov
Hepatocyte nuclear factor 4-alpha (HNF4α) is a highly conserved member of nuclear
receptor superfamily of ligand-dependent transcription factors that is expressed in liver and …

[HTML][HTML] A metformin-responsive metabolic pathway controls distinct steps in gastric progenitor fate decisions and maturation

ZF Miao, M Adkins-Threats, JR Burclaff, LH Osaki… - Cell Stem Cell, 2020 - cell.com
Cellular metabolism plays important functions in dictating stem cell behaviors, although its
role in stomach epithelial homeostasis has not been evaluated in depth. Here, we show that …

[HTML][HTML] Unravel the molecular mechanism of XBP1 in regulating the biology of cancer cells

W Shi, Z Chen, L Li, H Liu, R Zhang, Q Cheng… - Journal of …, 2019 - ncbi.nlm.nih.gov
Cancer cells are usually exposed to stressful environments, such as hypoxia, nutrient
deprivation, and other metabolic dysfunctional regulation, leading to continuous …

HNF4α isoforms: the fraternal twin master regulators of liver function

SH Radi, K Vemuri, J Martinez-Lomeli… - Frontiers in …, 2023 - frontiersin.org
In the more than 30 years since the purification and cloning of Hepatocyte Nuclear Factor 4
(HNF4α), considerable insight into its role in liver function has been gleaned from its target …

Metaplastic regeneration in the mouse stomach requires a reactive oxygen species pathway

ZF Miao, JX Sun, XZ Huang, S Bai, MJ Pang, JY Li… - Developmental Cell, 2024 - cell.com
In pyloric metaplasia, mature gastric chief cells reprogram via an evolutionarily conserved
process termed paligenosis to re-enter the cell cycle and become spasmolytic polypeptide …

Phosphomannomutase 2 (PMM2) variants leading to hyperinsulinism-polycystic kidney disease are associated with early-onset inflammatory bowel disease and …

F Kiparissi, A Dastamani, L Palm, A Azabdaftari… - Human Genetics, 2023 - Springer
Abstract Phosphomannomutase 2 (PMM2) deficiency causes Congenital Disorder of
Glycosylation (PMM2-CDG), but does not have a recognised association with Inflammatory …

Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4α and SIX1/4

SA Camolotto, VK Belova, L Torre-Healy… - Gut, 2021 - gut.bmj.com
Objective Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a 5-
year survival of less than 5%. Transcriptomic analysis has identified two clinically relevant …

Decoding spatiotemporal transcriptional dynamics and epithelial fibroblast crosstalk during gastroesophageal junction development through single cell analysis

N Kumar, PG Prakash, C Wentland, SM Kurian… - Nature …, 2024 - nature.com
The gastroesophageal squamocolumnar junction (GE-SCJ) is a critical tissue interface
between the esophagus and stomach, with significant relevance in the pathophysiology of …

HNF4α pathway map** identifies wild-type IDH1 as a targetable metabolic node in gastric cancer

C Xu, WF Ooi, A Qamra, J Tan, BYJ Chua, SWT Ho… - Gut, 2020 - gut.bmj.com
Objective Gastric cancer (GC) is a leading cause of cancer mortality. Previous studies have
shown that hepatocyte nuclear factor-4α (HNF4α) is specifically overexpressed in GC and …